Literature DB >> 29644912

Amalgamation of systemic inflammatory response syndrome score with C-reactive protein level in evaluating acute pancreatitis severity in children.

Wei Zheng1, Linqian Zhang1, Gao Long1, Bo Chen1, Xiaoli Shu1, Mizu Jiang1.   

Abstract

BACKGROUND AND AIM: Systemic inflammatory response syndrome (SIRS) has to do with how the body reacts to injury. Herein, we analyzed the clinical features of acute pancreatitis (AP) in children with SIRS complication and investigated the role of SIRS score combined with C-reactive protein (CRP) level in assessing AP severity in children.
METHODS: This retrospective cohort study involved 111 children hospitalized with AP at the Children's Hospital of Zhejiang University School of Medicine between January 2012 and August 2017. Presence of SIRS, demographic data, clinical information and laboratory test results on admission were statistically examined.
RESULTS: Out of the 111 AP cases, 45 were diagnosed with SIRS. Differences in CRP, interleukin-6 (IL-6), age, temperature, heart rate (HR), white blood cell (WBC), neutrophil count (NC), body mass index (BMI), duration of onset of disease symptoms as well as cases requiring intensive care unit (ICU) treatment were significantly higher in patients with SIRS than those without SIRS (p < .01 or p < .05). Logistic regression analyses evinced two independent risk factors for SIRS to be coexisted diseases (odds ratio (OR) = 4.871, p = .02) and fever (OR = 3.56, p = .007). SIRS was an independent predictor for AP severity (OR = 10.820, p = .005). The optimal cut-off value of CRP was 27.5 mg/L for severe AP classification according to receiver operating characteristic (ROC) (area under curve was 0.733).
CONCLUSION: Amalgamation of SIRS criterion with CRP level potentially plays an important role in assessing AP severity in children.

Entities:  

Keywords:  Acute pancreatitis; C-reactive protein; children; systemic inflammatory response syndrome

Mesh:

Substances:

Year:  2018        PMID: 29644912     DOI: 10.1080/00365521.2018.1459825

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

Review 1.  Etiology, case fatality, recurrence, and severity in pediatric acute pancreatitis: a meta-analysis of 48 studies.

Authors:  Guo Tian; Lu Zhu; Shuochun Chen; Qiyu Zhao; Tian'an Jiang
Journal:  Pediatr Res       Date:  2021-03-19       Impact factor: 3.756

2.  High-Fat Diet Aggravates the Intestinal Barrier Injury via TLR4-RIP3 Pathway in a Rat Model of Severe Acute Pancreatitis.

Authors:  Ying-Ru Su; Yu-Pu Hong; Fang-Chao Mei; Chen-Yang Wang; Man Li; Yu Zhou; Kai-Liang Zhao; Jia Yu; Wei-Xing Wang
Journal:  Mediators Inflamm       Date:  2019-12-17       Impact factor: 4.711

3.  Procalcitonin, C-Reactive Protein, and Neutrophil Ratio Contribute to the Diagnosis and Prognosis of Severe Acute Pancreatitis.

Authors:  Yi Liang; Xianwei Zhao; Fanliang Meng
Journal:  Iran J Public Health       Date:  2019-12       Impact factor: 1.429

4.  Cardiac indicator CK-MB might be a predictive marker for severity and organ failure development of acute pancreatitis.

Authors:  Bing Zhao; Silei Sun; Yihui Wang; Huihui Zhu; Tongtian Ni; Xing Qi; Lili Xu; Yuming Wang; Yi Yao; Li Ma; Ying Chen; Jun Huang; Weijun Zhou; Zhitao Yang; Huiqiu Sheng; Hongping Qu; Erzhen Chen; Jian Li; Enqiang Mao
Journal:  Ann Transl Med       Date:  2021-03

5.  Baseline Serum Estradiol Level Is Associated with Acute Kidney Injury in Patients with Moderately Severe and Severe Acute Pancreatitis.

Authors:  Jia-Jia Pan; Wei-Li Liu; Guo-Tao Lu; Xing-Jie Ma; Qing-Bin Zheng; Guang-Fa Wei; Ge-Yan Tian; Li-Jun Meng
Journal:  Gastroenterol Res Pract       Date:  2022-06-25       Impact factor: 1.919

6.  Admission risk factors and predictors of moderate or severe pediatric acute pancreatitis: A systematic review and meta-analysis.

Authors:  Márk Félix Juhász; Zoltán Sipos; Klementina Ocskay; Péter Hegyi; Anikó Nagy; Andrea Párniczky
Journal:  Front Pediatr       Date:  2022-09-30       Impact factor: 3.569

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.